GSK, Regional Health Outcomes Department, Singapore.
The National University of Malaysia, Faculty of Medicine, Kuala Lumpur, Malaysia.
Value Health Reg Issues. 2020 May;21:172-180. doi: 10.1016/j.vhri.2019.11.001. Epub 2020 Feb 7.
Countries have constrained healthcare budgets and must prioritize new interventions depending on health goals and time frame. This situation is relevant in the sphere of national immunization programs, for which many different vaccines are proposed, budgets are limited, and efficient choices must be made in the order of vaccine introduction.
A constrained optimization (CO) model for infectious diseases was developed in which different intervention types (prophylaxis and treatment) were combined for consideration in Malaysia. Local experts defined their priority public health issues: pneumococcal disease, dengue, hepatitis B and C, rotavirus, neonatal pertussis, and cholera. Epidemiological, cost, and effectiveness data were informed from local or regionally published literature. The model aimed to maximize quality-adjusted life-year (QALY) gain through the reduction of events in each of the different diseases, under budget and intervention coverage constraints. The QALY impact of the interventions was assessed over 2 periods: lifetime and 20 years. The period of investment was limited to 15 years.
The assessment time horizon influenced the prioritization of interventions maximizing QALY gain. The incremental health gains compared with a uninformed prioritization were large for the first 8 years and declined thereafter. Rotaviral and pneumococcal vaccines were identified as key priorities irrespective of time horizon, hepatitis B immune prophylaxis and hepatitis C treatment were priorities with the lifetime horizon, and dengue vaccination replaced these with the 20-year horizon.
CO modeling is a useful tool for making economically efficient decisions within public health programs for the control of infectious diseases by helping prioritize the selection of interventions to maximize health gain under annual budget constraints.
各国的医疗保健预算有限,必须根据健康目标和时间框架对新干预措施进行优先排序。这种情况与国家免疫规划领域相关,因为针对许多不同的疫苗提出了建议,预算有限,必须在疫苗引入的顺序中做出有效的选择。
我们开发了一种传染病约束优化(CO)模型,在该模型中,结合了不同的干预类型(预防和治疗),以考虑马来西亚的情况。当地专家确定了他们的优先公共卫生问题:肺炎球菌病、登革热、乙型和丙型肝炎、轮状病毒、新生儿百日咳和霍乱。流行病学、成本和有效性数据来自当地或地区发表的文献。该模型旨在通过减少每种不同疾病的事件来最大限度地提高质量调整生命年(QALY)收益,同时受预算和干预覆盖范围的限制。干预措施的 QALY 影响在两个时期内进行评估:终身和 20 年。投资期限于 15 年。
评估时间范围影响了最大化 QALY 收益的干预措施的优先级排序。与无信息优先排序相比,在最初 8 年内,增量健康收益较大,此后则下降。轮状病毒和肺炎球菌疫苗被确定为关键优先事项,无论时间范围如何,乙型肝炎免疫预防和丙型肝炎治疗都是终身时间范围内的优先事项,而登革热疫苗则在 20 年时间范围内取代了这些优先事项。
CO 建模是在控制传染病的公共卫生计划中做出经济高效决策的有用工具,通过帮助在年度预算限制下优先选择干预措施来最大化健康收益。